MiRNA-Regulated Pathways for Hypertrophic Cardiomyopathy: Network-Based Approach to Insight into Pathogenesis
Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease. The wide spread of high-throughput sequencing casts doubt on its monogenic nature, suggesting the presence of mechanisms of HCM development independent from mutations in sarcomeric genes. From this point of view, HCM may...
Main Authors: | German Osmak, Natalia Baulina, Ivan Kiselev, Olga Favorova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/12/2016 |
Similar Items
-
From miRNA Target Gene Network to miRNA Function: miR-375 Might Regulate Apoptosis and Actin Dynamics in the Heart Muscle via Rho-GTPases-Dependent Pathways
by: German Osmak, et al.
Published: (2020-12-01) -
Circulating miR-499a-5p Is a Potential Biomarker of <i>MYH7</i>—Associated Hypertrophic Cardiomyopathy
by: Natalia Baulina, et al.
Published: (2022-03-01) -
Hypertrophic cardiomyopathy
by: Sarita Gore, et al.
Published: (2022-01-01) -
A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy
by: Tilo Thottakara, et al.
Published: (2021-11-01) -
Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
by: Michele Salemi, et al.
Published: (2022-12-01)